Abbott Labs Hit With $15M Verdict In Depakote Trial

Law360, Chicago (June 9, 2017, 1:09 PM EDT) -- An Illinois federal jury found that Abbott Laboratories failed to properly warn doctors about the risk of a severe birth defect in the babies of women taking its blockbuster drug Depakote on Friday, awarding a 10-year-old boy born with the defect $15 million.

The jury declined to levy punitive damages against Abbott in a separate proceeding that immediately followed the verdict. (AP) After nearly two full days of deliberation, the jury agreed with attorneys for Stevie Gonzalez and his family that doctors who prescribed the drug to his mother, Christina Raquel, were not aware that her risk of having a baby born...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!